tamibarotene has been researched along with Ureteral Obstruction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Ge, S; Li, L; Luo, R; Xu, G; Yang, Y | 1 |
1 other study(ies) available for tamibarotene and Ureteral Obstruction
| Article | Year |
|---|---|
Tamibarotene inhibit the accumulation of fibrocyte and alleviate renal fibrosis by IL-17A.
Topics: Adult; Animals; Benzoates; Female; Fibroblasts; Fibrosis; Humans; Interleukin-17; Kidney; Macrophages; Male; Mice, Inbred C57BL; Middle Aged; Tetrahydronaphthalenes; Ureteral Obstruction | 2020 |